Related Experiment Video
Updated: Jul 4, 2026
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
A national study on lipid management
Alan B Jotkowitz1, Victor Novack, Gad Rabinowitz
1Department of Internal Medicine F, Soroka University Medical Center, Faculty of the Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. ajotkowitz@hotmail.com
Insights
This study shows improved LDL cholesterol testing and treatment goal achievement for cardiovascular disease prevention. Continued efforts are necessary to further enhance patient outcomes in hyperlipidemia management.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Hyperlipidemia is a significant contributor to cardiovascular morbidity in Western populations.
- Assessing LDL cholesterol measurement rates and goal attainment is crucial for effective cardiovascular disease (CVD) prevention.
- This study focuses on primary and secondary prevention strategies for hyperlipidemia.
Purpose of the Study:
- To determine the percentage of adults undergoing regular LDL cholesterol measurements.
- To evaluate the proportion of diabetic and post-angioplasty patients achieving target LDL cholesterol levels.
- To analyze trends in LDL measurement and treatment goal attainment over time.
Main Methods:
- Utilized a national database to extract data on LDL cholesterol testing rates.
- Assessed LDL cholesterol levels and treatment goal attainment in diabetic and post-angioplasty cohorts.
- Collected data from patients with acute coronary syndrome (ACS) admitted between 2000-2004.
Main Results:
- In 2005, LDL cholesterol measurement was documented in 64.6% of adults aged 35-44 and 79.6% aged 45-54.
- 86.9% of diabetic patients had at least one annual LDL measurement; statin therapy use increased significantly post-ACS (87%).
- Among post-PTCA patients, 57.8% achieved LDL <100 mg/dl, with high rates of statin prescription and LDL measurement.
Conclusions:
- Significant improvements observed in primary and secondary prevention of CVD through increased LDL measurement and goal attainment.
- While progress has been made, further interventions are required to optimize hyperlipidemia management.
- The findings highlight the importance of regular monitoring and adherence to treatment goals for reducing cardiovascular risk.
Background:
Hyperlipidemia remains a major cause of morbidity in Western countries. The objective of this study was to document the percentage of adults who underwent periodical LDL measurement, and the percentage of patients with diabetes and post-angioplasty who were treated to goal.
Methods:
Using a national database, data were obtained on the percentage of adults who had an LDL performed and the percentage of adults with an LDL at pre-specified levels. We also assessed the attainment of target LDL levels in diabetic and post-angioplasty patients. Data were also collected from patients with an acute coronary syndrome (ACS) admitted to seven hospitals within a 5 year period (2000-2004).
Results:
Primary prevention: In 2005, 64.6% of the total population of 754,910 aged 35-44 had at least one record of LDL cholesterol measurement documented. This figure was 79.6% in the 717,617 adults aged 45-54. Secondary prevention: Of 253,233 diabetics in 2005, 220,023 (86.9%) have undergone at least one annual LDL measurement. The percentage of patients on statin therapy 3 and 12 months after an ACS admission increased significantly during the years 2000-2004 and reached 87%. Of the 42,292 patients who underwent PTCA during 2005, 34,346 (81.2%) have purchased at least 3 prescriptions of statins during 2005, 35,261 (83.4%) have performed at least one LDL measurement and 57.8% attained an LDL level of <100 mg/dl.
Conclusions:
We have shown an improvement in primary and secondary preventions of CV disease as documented by LDL measured and attainment of treatment goals, but further efforts are needed.
Related Concept Videos
01:26Atherosclerosis III: Management
01:24Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:24Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
01:06Lipid Digestion